HealthVerity releases the Provider Diversity Index 2023 edition to increase diversity in clinical trials
PHILADELPHIA, July 18, 2023 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced the release of the Provider Diversity Index (PDI) 2023 edition with breakthrough enhancements that help pharmaceutical manufacturers to prioritize physicians who are treating patients more reflective of the populations impacted by the conditions being studied.
- The HealthVerity PDI is being actively used by clients to identify clinical trial site investigators and to more effectively characterize and recruit patient populations that better reflect the diversity mix of diagnosed patients.
- New enhancements to the HealthVerity PDI for 2023, such as age range, gender, income range, payer type (commercial, Medicare or Medicaid) and diagnosis further the mission of pharmaceutical manufacturers and CROs in achieving their diversity goals.
- According to the 2020 U.S. Census, 57.8% of the population is White/Caucasian, 12.1% is Black/African American and 18.7% of the population is Hispanic/Latino.
- "We are proud to have the advanced technologies and privacy techniques to enable our clients to practice better medicine through diversity."